Table 1.

Characteristics of pilot study participants

ID	Age	Gender	Place of residence*	Date of Mel Dx	Site	Stage
001	46	F	Accessible rural	2010	Arm	1.1 mm stage 1B
002	49	F	Other urban area	2012	Knee	0.5 mm stage 1A
003	72	F	Accessible rural	2013	Arm	0.4 mm stage 1A
004	69	M	Urban	2013	Breast	0.8 mm stage 1A
005	62	M	Remote rural	2012	Eyelid	M in situ stage 0
006	66	F	Remote rural	2011	Cheek	0.3 mm stage 1A
007	72	M	Remote small town	2009	Cheek	2.8 mm stage 2A
008	70	M	Remote small town	2012	Shoulder	0.3 mm stage 1A
009*	41	F	Remote rural	2011	Back	>1 mm
010	67	F	Accessible rural	2009	Arm	3 mm stage 2A
011	78	M	Remote small town	2008	Eyebrow	2.6 mm stage 2A
012	42	F	Accessible small town	2011	Back	M in situ stage 0
013	75	F	Accessible rural	2009	Thigh	1.1 mm stage 2B
014	67	M	Accessible rural	2013	Shoulder	2 mm stage 2A
015	46	F	Accessible rural	2011	Abdomen	0.6 mm stage 1A
016	72	M	Accessible rural	2011	Forearm	1 mm stage 1B
017	65	M	Accessible rural	2014	Shoulder	M in situ stage 0
018	69	M	Remote rural	2009	Shoulder	1.5 mm stage 1B
019	44	M	Accessible rural	2012	Abdomen	1.5 mm stage 1B
020	44	F	Accessible small town	2010	Lower leg	0.42 mm stage1A

Classifications from Scottish Government Urban-Rural Classification.³⁸

*Staging data were not available for this patient. M, melanoma; Mel Dx, melanoma diagnosis.